Evidence map›Paper›PMID 29335358›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2018

Sox2 Is Essential for Oligodendroglial Proliferation and Differentiation during Postnatal Brain Myelination and CNS Remyelination.

Sheng Zhang, Xiaoqing Zhu, Xuehong Gui, Christopher Croteau, Lanying Song, Jie Xu, Aijun Wang, Peter Bannerman, Fuzheng Guo

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
5.4field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 105 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Review
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 2 countries.

Sheng ZhangInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.ORCID 0000-0002-0692-8999
Xiaoqing ZhuInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.
Xuehong GuiInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.
Christopher CroteauInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.
Lanying SongInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.
Jie XuInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.
Aijun WangInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.ORCID 0000-0002-2985-3627
Peter BannermanInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817.
Fuzheng GuoInstitute for Pediatric Regenerative Medicine, Shriners Hospitals for Children, Northern California, California 95817, fzguo@ucdavis.edu.ORCID 0000-0003-3410-8389
Shriners Hospitals for Children - Northern California · USQingdao University · CN

Funding

Fetal Tissue Engineering to Treat Spina Bifida Before BirthR01NS100761 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI WANG, AIJUN · 2017 to 2021
$1.7M
The Wnt-independent role of TCF7l2 in CNS myelin formation and repairR01NS094559 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GUO, FUZHENG · 2016 to 2020
$1.4M
The curious case of Wnt effector TCF712 in CNS myelination and remyelinationR21NS093559 · NINDS · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GUO, FUZHENG · 2016 to 2016
$235k
NINDS NIH HHS R01 NS094559NINDS NIH HHS R01 NS100761NINDS NIH HHS R21 NS093559
6 · The paper itself

Abstract

In the CNS, myelination and remyelination depend on the successful progression and maturation of oligodendroglial lineage cells, including proliferation and differentiation of oligodendroglial progenitor cells (OPCs). Previous studies have reported that Sox2 transiently regulates oligodendrocyte (OL) differentiation in the embryonic and perinatal spinal cord and appears dispensable for myelination in the postnatal spinal cord. However, the role of Sox2 in OL development in the brain has yet to be defined. We now report that Sox2 is an essential positive regulator of developmental myelination in the postnatal murine brain of both sexes. Stage-specific paradigms of genetic disruption demonstrated that Sox2 regulated brain myelination by coordinating upstream OPC population supply and downstream OL differentiation. Transcriptomic analyses further supported a crucial role of Sox2 in brain developmental myelination. Consistently, oligodendroglial Sox2-deficient mice developed severe tremors and ataxia, typical phenotypes indicative of hypomyelination, and displayed severe impairment of motor function and prominent deficits of brain OL differentiation and myelination persisting into the later CNS developmental stages. We also found that Sox2 was required for efficient OPC proliferation and expansion and OL regeneration during remyelination in the adult brain and spinal cord. Together, our genetic evidence reveals an essential role of Sox2 in brain myelination and CNS remyelination, and suggests that manipulation of Sox2 and/or Sox2-mediated downstream pathways may be therapeutic in promoting CNS myelin repair.

Indexed as

AnimalsBrainCell DifferentiationCell ProliferationCentral Nervous SystemDemyelinating DiseasesFemaleMaleMiceMice, Inbred C57BLMice, KnockoutMice, TransgenicMovement DisordersMyelin SheathNerve RegenerationOligodendrogliaSox2 protein, mouseSOXB1 Transcription Factorsmyelination and remyelinationoligodendrocyte differentiationoligodendrocyte regenerationoligodendroglial lineage progressionoligodendroglial progenitor cellsSox2

Identifiers

PMID29335358
PMCPMC5815459
OpenAlexW2784152931

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.